| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/15/2014 | CN103509113A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 01/15/2014 | CN103509112A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 01/15/2014 | CN103509111A Human anti-KIR antibodies |
| 01/15/2014 | CN103505718A Compstatin and analogs thereof for eye disorders |
| 01/15/2014 | CN102964427B Bioactive polypeptide QEPVL, and preparation and application thereof |
| 01/15/2014 | CN102191255B Preparation and application of recombinant plectasin |
| 01/15/2014 | CN102099468B Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 01/14/2014 | US8629325 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 01/14/2014 | US8629324 Polypeptides having expansin activity and polynucleotides encoding same |
| 01/14/2014 | US8629323 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 01/14/2014 | US8629317 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof |
| 01/14/2014 | US8629260 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 01/14/2014 | US8629248 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/14/2014 | US8629246 Dual specificity antibody fusions |
| 01/14/2014 | US8628939 Expression vector containing the major envelope protein P9 of cystovirus PHI6 as a fusion partner, and process for producing a membrane protein using the same |
| 01/14/2014 | US8628938 Polynucleotide encoding UDP-glucuronyl transferase |
| 01/14/2014 | US8628777 Antibodies binding IL-1 related polypeptides |
| 01/14/2014 | US8628749 Radioimmunoconjugates and uses thereof |
| 01/14/2014 | CA2687082C Improved feed media |
| 01/14/2014 | CA2601368C Monoclonal and polyclonal antibodies to equine albumin and hemoglobin and apparatus and methods using the antibodies in the identification and localization of ulcers and other digestive tract bleeding in equines |
| 01/14/2014 | CA2445602C Nucleotide sequence for creatinine deiminase and method of use |
| 01/14/2014 | CA2418088C Numb protein expression inhibitors by musashi 1 |
| 01/09/2014 | WO2014008440A2 Aptamers for prion diagnostics and aptamer binding detection system |
| 01/09/2014 | WO2014007198A1 Therapeutic agent for anemia including renal anemia and cancer-induced anemia which contains anti-bmp9 antibody as active ingredient |
| 01/09/2014 | WO2014006226A1 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO |
| 01/09/2014 | WO2014006040A1 Inactivation of a production strain using a fatty acid |
| 01/09/2014 | WO2013163631A3 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof |
| 01/09/2014 | US20140013457 Methods of Modifying Eukaryotic Cells |
| 01/09/2014 | US20140011981 Expression and secretion system |
| 01/09/2014 | US20140011262 Methods For Producing Secreted Polypeptides |
| 01/09/2014 | US20140011239 Method for Enhancing Extracellular Secretion of Recombinant Proteins in Escherichia coli by Co-expressing Thermobifida Fusca Cutinase |
| 01/09/2014 | US20140011237 Chinese Hamster Ovary Cell Line |
| 01/09/2014 | US20140011236 Promoters for high level recombinant expression in fungal host cells |
| 01/09/2014 | US20140011235 Release factor 1 (rf1) in escherichia coli |
| 01/09/2014 | US20140011188 Methods for producing virus particles with simplified glycosylation of surface proteins |
| 01/09/2014 | US20140010843 Method of detoxification |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | CA2876541A1 Mutant fragments of ospa and methods and uses relating thereto |
| 01/08/2014 | EP2682474A1 Preparation method of new recombinant antibacterial polypeptide medicine |
| 01/08/2014 | EP2682464A1 Fibrinogen-producing transgenic silkworm |
| 01/08/2014 | EP2682463A1 Bacteriocin derived from lactobacillus rhamnosus |
| 01/08/2014 | EP2681327A2 Vectors conditionally expressing protein |
| 01/08/2014 | EP2681326A2 Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties |
| 01/08/2014 | EP2681308A1 Protein expression |
| 01/08/2014 | EP2681280A1 Biomaterial, method for making the biomaterial and uses of the same |
| 01/08/2014 | CN103502516A Artificial polypeptide fiber and method for producing same |
| 01/08/2014 | CN103502464A Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
| 01/08/2014 | CN103497986A Enzyme-method rice starch and rice protein co-production process |
| 01/08/2014 | CN103497985A Walnut protein antioxidant peptides and preparation method thereof |
| 01/08/2014 | CN103497984A Preparation method of rice enzymolysis selenium polypeptides with immune activity |
| 01/08/2014 | CN103497237A Alpha-MSH analogue with therapeutic activity |
| 01/08/2014 | CN103493969A Method for producing giant salamander polypeptide powder |
| 01/08/2014 | CN102690853B Preparation method of sleeve-fish skin low-molecular-weight collagen peptide |
| 01/08/2014 | CN102676623B Method for preparing antioxidant peptide from shrimp shell |
| 01/08/2014 | CN101516901B Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 01/08/2014 | CN101432301B Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/08/2014 | CN101031318B Cellular permissivity factor for viruses and uses thereof |
| 01/07/2014 | US8624085 Insect resistant protein and insect-resistance gene encoding the insect-resistant protein |
| 01/07/2014 | US8624082 Polypeptides having xylanase activity and polynucleotides encoding same |
| 01/07/2014 | US8624007 Alteration of Fc-fusion protein serum half-lives by mutagenesis |
| 01/07/2014 | US8624004 Purification of HBV antigens for use in vaccines |
| 01/07/2014 | US8624001 Anti-CD19 antibodies |
| 01/07/2014 | US8623810 Protease for wound conditioning and skin care |
| 01/07/2014 | US8623644 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/07/2014 | US8623631 Modified promoter |
| 01/07/2014 | US8623626 Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract |
| 01/07/2014 | US8623625 Sulfotransferase, peptide thereof and DNA encoding the same |
| 01/07/2014 | US8623618 Engineered cleavage half-domains |
| 01/07/2014 | US8623615 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
| 01/07/2014 | US8623376 Chimeric OspA genes, proteins, and methods of use thereof |
| 01/07/2014 | US8623375 Chimeric OspA genes, proteins, and methods of use thereof |
| 01/07/2014 | US8623366 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 01/07/2014 | US8623364 Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 01/07/2014 | US8623348 Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) |
| 01/07/2014 | CA2584719C High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 01/07/2014 | CA2461372C Dna sequences for human angiogenesis genes |
| 01/07/2014 | CA2441820C Evolving new molecular function |
| 01/07/2014 | CA2319404C Recombinant lipidated psaa protein, methods of preparation and use |
| 01/07/2014 | CA2318405C Antibodies to death receptor 4(dr4) and uses thereof |
| 01/03/2014 | WO2014005036A1 Method of producing recombinant iduronate-2-sulfatase |
| 01/03/2014 | WO2014003137A1 High-affinity antibody, and production method therefor |
| 01/03/2014 | WO2014002424A1 Molecular engineering method for in vitro evolution of membrane protein |
| 01/03/2014 | WO2014001324A1 Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof |
| 01/03/2014 | WO2014001261A1 Fermentation process |
| 01/03/2014 | CA2877521A1 Cells for producing recombinant iduronate-2-sulfatase |
| 01/03/2014 | CA2877492A1 Method of producing recombinant iduronate-2-sulfatase |
| 01/02/2014 | US20140005365 Antibody to a mutant g-csf for diagnosis of cancer |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004566 Fusion Partner for Production of Monoclonal Rabbit Antibodies |
| 01/02/2014 | US20140004123 Monoclonal antibody production by ebv transformation of b cells |
| 01/01/2014 | EP2679682A1 Alkaline phosphatase |
| 01/01/2014 | EP2678440A2 Yeast strain for the production of proteins with modified o-glycosylation |
| 01/01/2014 | EP2678359A2 Combination therapies comprising anti-erbb3 agents |
| 01/01/2014 | CN203370139U Injectable tissue engineering cartilage in-vitro construction device |
| 01/01/2014 | CN103492584A Compositions containing glycosylated antibodies and uses thereof |
| 01/01/2014 | CN103492583A Dual variable domain immunoglobulins and uses thereof |
| 01/01/2014 | CN103492582A Compositions and methods of use for determination of HE4a |
| 01/01/2014 | CN103492417A Tumor specific antibodies and uses therefor |
| 01/01/2014 | CN103492415A Antibody to signal peptide of amyloid precursor protein |